Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a): A Phase 2 Randomized Clinical Trial
Oral Muvalaplin for Lowering of Lipoprotein(a): A Randomized Clinical Trial
Bempedoic Acid for Prevention of Cardiovascular Events in People With Obesity: A CLEAR Outcomes Subset Analysis
Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk
Efficacy and Safety of Inclisiran in Adolescents With Genetically Confirmed Homozygous Familial Hypercholesterolemia: Results From the Double-Blind, Placebo-Controlled Part of the ORION-13 Randomized Trial
Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3
Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk
